Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 997

    1.

    Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

    Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL.

    Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.PMID: 18838724 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

    Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME; Colorectal Cancer Study Group.

    N Engl J Med. 2004 Dec 23;351(26):2704-14.PMID: 15616205 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Stool DNA and occult blood testing to screen for colorectal neoplasia.

    [No authors listed]

    Ann Intern Med. 2008 Oct 7;149(7):I20. No abstract available. PMID: 18838720 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.

    Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL, Levine TR, Rex DK, Ahnen D, Knigge KL, Lance P, Jiang X, Smith DI, Ahlquist DA.

    Gastroenterology. 2009 Feb;136(2):459-70. Epub 2008 Oct 15.PMID: 19026650 [PubMed - indexed for MEDLINE]Related articles

    5.

    Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.

    Rozen P, Knaani J, Samuel Z.

    Dig Dis Sci. 1997 Oct;42(10):2064-71.PMID: 9365136 [PubMed - indexed for MEDLINE]Related articles

    6.

    Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.

    Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD.

    JAMA. 1993 Mar 10;269(10):1262-7.PMID: 8437303 [PubMed - indexed for MEDLINE]Related articles

    7.

    Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.

    Kristinsson J, Nygaard K, Aadland E, Barstad S, Sauar J, Hofstad B, Stray N, Stallemo A, Haug B, Ugstad M, Tøn H, Fuglerud P.

    Digestion. 2001;64(2):104-10.PMID: 11684824 [PubMed - indexed for MEDLINE]Related articles

    8.

    Patient perceptions of stool-based DNA testing for colorectal cancer screening.

    Schroy PC 3rd, Heeren TC.

    Am J Prev Med. 2005 Feb;28(2):208-14.PMID: 15710277 [PubMed - indexed for MEDLINE]Related articles

    9.

    Evaluation of new occult blood tests for detection of colorectal neoplasia.

    St John DJ, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, Penfold JC.

    Gastroenterology. 1993 Jun;104(6):1661-8.PMID: 8500724 [PubMed - indexed for MEDLINE]Related articles

    10.

    A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.

    Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC.

    Am J Gastroenterol. 2000 May;95(5):1331-8.PMID: 10811348 [PubMed - indexed for MEDLINE]Related articles

    11.

    Options for screening for colorectal cancer.

    Atkin W.

    Scand J Gastroenterol Suppl. 2003;(237):13-6. Review.PMID: 12797674 [PubMed - indexed for MEDLINE]Related articles

    13.

    Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia.

    Tagore KS, Lawson MJ, Yucaitis JA, Gage R, Orr T, Shuber AP, Ross ME.

    Clin Colorectal Cancer. 2003 May;3(1):47-53.PMID: 12777192 [PubMed - indexed for MEDLINE]Related articles

    14.

    A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

    Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

    Ann Intern Med. 2007 Feb 20;146(4):244-55.PMID: 17310048 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.

    Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Göke B, Lamerz R, Kolligs FT.

    Clin Gastroenterol Hepatol. 2005 Feb;3(2):142-9.PMID: 15704048 [PubMed - indexed for MEDLINE]Related articles

    16.

    Colocare self-test versus Hemoccult II Sensa for fecal occult blood testing.

    Foliente RL, Wise GR, Collen MJ, Abdulian JD, Chen YK.

    Am J Gastroenterol. 1995 Dec;90(12):2160-3.PMID: 8540507 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.

    Limburg PJ, Devens ME, Harrington JJ, Diehl NN, Mahoney DW, Ahlquist DA.

    Am J Gastroenterol. 2003 Oct;98(10):2299-305.PMID: 14572583 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.

    St John DJ, Young GP, McHutchison JG, Deacon MC, Alexeyeff MA.

    Ann Intern Med. 1992 Sep 1;117(5):376-82.PMID: 1503328 [PubMed - indexed for MEDLINE]Related articles

    19.

    Patterns of occult bleeding in asymptomatic colorectal cancer.

    Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS, Rubin J, Moertel CG.

    Cancer. 1989 May 1;63(9):1826-30.PMID: 2702590 [PubMed - indexed for MEDLINE]Related articles

    20.

    Colon cancer screening strategies.

    Agrawal J, Syngal S.

    Curr Opin Gastroenterol. 2005 Jan;21(1):59-63. Review.PMID: 15687886 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data